L1898

[D-Ala⁶]-LH-RH acetate salt hydrate

≥97% (HPLC), LH-RH agonist

• Synonim(y): (D-Ala-⁶) Luteinizing Hormone Releasing Hormone
• Wzór empiryczny (zapis Hilla): C₅₆H₇₇N₁₇O₁₃ · xC₂H₄O₂ · yH₂O
• Masa cząsteczkowa: 1196.32 (anhydrous free base basis)
• UNSPSC Code: 12352209
• PubChem Substance ID: 24896296
• NACRES: NA.77

Właściwości

• Nazwa produktu: [D-Ala⁶]-LH-RH acetate salt hydrate, ≥97% (HPLC)
• Quality Segment: 200
• assay: ≥97% (HPLC)
• composition: Peptide content, ≥65%
• UniProt accession no.: P01148
• storage temp.: −20°C
• SMILES string: [H]O[H].CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6C(=O)NCC(N)=O
• InChI: 1S/C56H77N17O13.C2H4O2.H2O/c1-29(2)20-39(50(81)67-38(10-6-18-61-56(58)59)55(86)73-19-7-11-44(73)54(85)63-26-45(57)76)68-47(78)30(3)65-49(80)40(21-31-12-14-34(75)15-13-31)69-53(84)43(27-74)72-51(82)41(22-32-24-62-36-9-5-4-8-35(32)36)70-52(83)42(23-33-25-60-28-64-33)71-48(79)37-16-17-46(77)66-37;1-2(3)4;/h4-5,8-9,12-15,24-25,28-30,37-44,62,74-75H,6-7,10-11,16-23,26-27H2,1-3H3,(H2,57,76)(H,60,64)(H,63,85)(H,65,80)(H,66,77)(H,67,81)(H,68,78)(H,69,84)(H,70,83)(H,71,79)(H,72,82)(H4,58,59,61);1H3,(H,3,4);1H2/t30-,37+,38+,39+,40+,41+,42+,43+,44+;;/m1../s1
• InChI key: KGUIXKYKIZMKMT-JGUOWLKQSA-N
• Gene Information: human ... GNRH1(2796)

Opis

Application

[D-Ala⁶]-LH-RH acetate salt hydrate has been used to induce ovulation and to synchronize the reproductive cycle in Sprague-Dawley female rats.[1]

Biochem/physiol Actions

(D-Ala⁶)-LH-RH is a GnRH (gonadotropin-releasing hormone) agonist.[2] GnRH, which is also referred to as LHRH (luteinizing hormone-releasing hormone) or gonadorelin, is crucial for mammalian reproduction and is released from hypothalamic neurons. It is responsible for the secretion of gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from pituitary glands.[3][4] Mutations in GnRH are associated with normosmic congenital hypogonadotropic hypogonadism.[4]

Potent LH-RH agonist.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS08
• signalword: Danger
• hcodes: H360
• pcodes: P201 - P308 + P313
• Hazard Classifications: Repr. 1B
• Klasa składowania: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type P3 (EN 143) respirator cartridges